Order Article Reprints

Kuncman Ł, Orzechowska M, Stawiski K, Masłowski M, Ciążyńska M, Gottwald L, Milecki T, Fijuth J. The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy. Cancers. 2022; 14(16):3844. https://doi.org/10.3390/cancers14163844

Kuncman, Łukasz, Magdalena Orzechowska, Konrad Stawiski, Michał Masłowski, Magdalena Ciążyńska, Leszek Gottwald, Tomasz Milecki, and Jacek Fijuth. 2022. "The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy" Cancers 14, no. 16: 3844. https://doi.org/10.3390/cancers14163844

Kuncman, Ł., Orzechowska, M., Stawiski, K., Masłowski, M., Ciążyńska, M., Gottwald, L., Milecki, T., & Fijuth, J. (2022). The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy. Cancers, 14(16), 3844. https://doi.org/10.3390/cancers14163844